This is an observational study called PROCCEED, which is part of a larger research effort by the NIH. It aims to understand chronic pancreatitis better by collecting and managing data from people with the condition. The study is not testing a new medicine or treatment. Instead, it's focused on gathering information to help researchers learn more about chronic pancreatitis. You could be eligible to join if you are between 18 and 75 years old and have chronic pancreatitis. However, you cannot join if you have certain other conditions like autoimmune pancreatitis or specific pancreatic tumors. The main goal is to track any safety issues or side effects that occur during the study, which is expected to last about one year on average. This study is not enrolling patients at MD Anderson Cancer Center; all participants will be recruited at other sites.

Study design

This is an observational study that plans to enroll 2345 participants. It is not testing a specific drug or intervention, but rather collecting data.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for safety and adverse events (side effects) through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.